The clinical impact of the detection of potential etiologic pathogens of community-acquired pneumonia

Diagnostic Microbiology and Infectious Disease

Volumn 83, Issue 4, 2015, Pages 400-406

  Gelfer, Gita ^a   Leggett, James ^a   Myers, Jillian ^a   Wang, Luan ^a   Gilbert, David N ^a  

^a PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

Author keywords

Community acquired pneumonia; Diagnostic bundles; FilmArray; Molecular diagnostics; Procalcitonin

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN; ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; CALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM IDENTIFICATION; BLOOD CULTURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG WITHDRAWAL; FEMALE; HORMONE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NOSE SMEAR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY VIRUS; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TURNAROUND TIME; VIRUS DETECTION; VIRUS PNEUMONIA; BACTERIUM; BLOOD; CHEMISTRY; CLASSIFICATION; COMMUNITY-ACQUIRED INFECTIONS; DRUG UTILIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; NOSE CAVITY; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; SPUTUM; URINE; VERY ELDERLY; VIROLOGY; VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIA; BLOOD; CALCITONIN; COMMUNITY-ACQUIRED INFECTIONS; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL CAVITY; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; POLYMERASE CHAIN REACTION; PROTEIN PRECURSORS; SPUTUM; URINE; VIRUSES;

EID: 84947017120     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2015.08.001     Document Type: Article

References (15)

1. Albrich W.C., Madhi S.A., Adrian P.V., Telles J.-N., Parankos-Baccala G., Klugman K.P. Genomic load from sputum samples and nasopharyngeal swabs for diagnosis of pneumococcal pneumonia in HIV-infected adults. J Clin Microbiol 2014, 52:4224-4229.
2. Becker K.L., Snider R., Nylen E.S. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008, 36:941-952.
3. Branche A.R., Walsh E.E., Vargas R., Hulbert B., Formica M.A., Baran A., et al. Serum procalcitonin and viral testing to guide antibiotic use for respiratory infections in hospitalized adults: a randomized controlled trial. J Infect Dis 2015, (Epub ahead of print). 10.1093/infdis/jiv253.
4. Falsey A.R., Becker K.L., Swinburne A.J., Nylen E.S., Snider R.H., Formica M.A., et al. Utility of serum procalcitonin values in patients with acute exacerbation of chronic obstructive pulmonary disease: a cautionary note. Int J COPD 2012, 7:127-135.
5. Gilbert D.N. Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis 2011, 52:S362.
6. Gilbert D.N. Where do we go from here (editorial). J Infect Dis 2015, 10.1093/infdis/jiv253.
7. Johansson N., Kalin M., Tiveljung-Lindell A., Giske C.G., Hedlund F. Etiology of community-acquired pneumonia: increased yield with new diagnostic methods. Clin Infect Dis 2010, 50:202.
8. Leone M., Malavieille F., Papazian L., Meyssignac B., Cassir N., Textoris J., et al. Routine use of Staphylococcus aureus rapid diagnostic test in patients with suspected ventilator-associated pneumonia. Crit Care 2013, 17:R170.
9. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44:S27-S72.
10. Musher D.M., Roig I.L., Cazares G., Stager C.E., Logan N., Safar H. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study. J Infect 2013, 67:11-18.
11. Oosterheert J.J., vanLoon A.M., Schuurman R., Hoepelman Andy I.M., Hak E., Thijsen S., et al. Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection. Clin Infect Dis 2005, 41:1438-1444.
12. Restrepo M.I., Mortensen E.M., Velez J.A., Frei C., Anzueto A. A comparative study of community-acquired pneumonia patients admitted to the ward and ICU. Chest 2008, 133:610-.
13. Schuetz P., Briel M., Christ-Crain M., Stolz D., Bouadma L., Wolff M., et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis 2012, 55:651-662.
14. Schuetz P., Briel M., Mueller B. Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections. JAMA 2013, 309:717-718.
15. Shibi F., Chazan B., Nitzan O., Flatau E., Edelstein H., Blondheim O., et al. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J 2010, 12:477-.